Trial Profile
A retrospective study to evaluate the efficacy of Temozolomide and Bevacizumab in patients with locally advanced metastatic hemangiopericytoma and malignant solitary fibrous tumor
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Temozolomide (Primary)
- Indications Soft tissue sarcoma; Tumours
- Focus Therapeutic Use
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 06 Jun 2017 New trial record